These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
898 related items for PubMed ID: 26268144
1. Multiparametric MRI of the prostate with three functional techniques in patients with PSA elevation before initial TRUS-guided biopsy. Hauth E, Hohmuth H, Cozub-Poetica C, Bernand S, Beer M, Jaeger H. Br J Radiol; 2015 Oct; 88(1054):20150422. PubMed ID: 26268144 [Abstract] [Full Text] [Related]
2. Multiparametric MRI in detection and staging of prostate cancer. Boesen L. Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066 [Abstract] [Full Text] [Related]
3. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial. Tonttila PP, Lantto J, Pääkkö E, Piippo U, Kauppila S, Lammentausta E, Ohtonen P, Vaarala MH. Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153 [Abstract] [Full Text] [Related]
4. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. Hoeks CM, Schouten MG, Bomers JG, Hoogendoorn SP, Hulsbergen-van de Kaa CA, Hambrock T, Vergunst H, Sedelaar JP, Fütterer JJ, Barentsz JO. Eur Urol; 2012 Nov; 62(5):902-9. PubMed ID: 22325447 [Abstract] [Full Text] [Related]
6. Evaluation of a structured report of functional prostate magnetic resonance imaging in patients with suspicion for prostate cancer or under active surveillance. Quentin M, Blondin D, Klasen J, Schek J, Buchbender C, Miese FR, Antoch G, Barski D, Albers P, Arsov C. Urol Int; 2012 Nov; 89(1):25-9. PubMed ID: 22677880 [Abstract] [Full Text] [Related]
7. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy. Sciarra A, Panebianco V, Cattarino S, Busetto GM, De Berardinis E, Ciccariello M, Gentile V, Salciccia S. BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540 [Abstract] [Full Text] [Related]
8. Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner. Singh AK, Krieger A, Lattouf JB, Guion P, Grubb RL, Albert PS, Metzger G, Ullman K, Smith S, Fichtinger G, Ocak I, Choyke P, Ménard C, Coleman J. BJU Int; 2008 Jan; 101(2):181-5. PubMed ID: 17922874 [Abstract] [Full Text] [Related]
10. The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage prostate cancer: the preliminary experience. Mouraviev V, Verma S, Kalyanaraman B, Zhai QJ, Gaitonde K, Pugnale M, Donovan JF. J Endourol; 2013 Jul; 27(7):820-5. PubMed ID: 22966987 [Abstract] [Full Text] [Related]
12. Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology? Abd-Alazeez M, Ahmed HU, Arya M, Allen C, Dikaios N, Freeman A, Emberton M, Kirkham A. Urol Oncol; 2014 Aug; 32(6):741-7. PubMed ID: 24981993 [Abstract] [Full Text] [Related]
13. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. Vilanova JC, Barceló-Vidal C, Comet J, Boada M, Barceló J, Ferrer J, Albanell J. AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259 [Abstract] [Full Text] [Related]
14. The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation. Mowatt G, Scotland G, Boachie C, Cruickshank M, Ford JA, Fraser C, Kurban L, Lam TB, Padhani AR, Royle J, Scheenen TW, Tassie E. Health Technol Assess; 2013 May; 17(20):vii-xix, 1-281. PubMed ID: 23697373 [Abstract] [Full Text] [Related]